Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer

Journal of Clinical Oncology

Volumn 19, Issue 22, 2001, Pages 4202-4208

  McGinn, C J ^a   Zalupski, M M ^a   Shureiqi, I ^a   Robertson, J M ^a   Eckhauser, F E ^a   Smith, D C ^a   Brown, D ^a   Hejna, G ^a   Strawderman, M ^a   Normolle, D ^a   Lawrence, T S ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GEMCITABINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD TOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE CALCULATION; DOSE RESPONSE; DRUG TOLERABILITY; DUODENUM ULCER; HUMAN; PANCREAS CANCER; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; STOMACH ULCER; VOMITING;

EID: 0035890443     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.22.4202     Document Type: Article

References (21)

1. Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil
2. Combined intraoperative radiation and perioperative chemotherapy for unresectable cancers of the pancreas
3. High-dose preoperative external beam and intraoperative irradiation for locally advanced pancreatic cancer
4. Intraoperative radiation therapy of pancreatic carcinoma: A report of RTOG-8505
5. Chemo-radiotherapy for localized pancreatic cancer: Increased dose intensity and reduced acute toxicity with concomitant radiotherapy and protracted venous infusion 5-fluorouracil
6. Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: A phase I Eastern Cooperative Oncology Group trial
7. Improvements in survival and clinical benefit with gemcitabine as first line therapy for patients with advanced pancreas cancer: A randomized trial
8. Radiosensitization of pancreatic cancer cells by 2′,2′-difluoro-2′-deoxycytidine
9. NCCN practice guidelines for pancreatic cancer
10. The clinical application of a non-axial treatment plan for pancreatic and biliary malignancies
11. Reporting results of cancer treatment
12. Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer
13. Difluorodeoxycytidine (dFdC)-gemcitabine: A phase I study
14. Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma
15. Maximizing therapeutic gain with gemcitabine and fractionated radiation
16. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas
17. Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma
18. Eastern Cooperative Oncology Group phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: A regimen with unexpected early toxicity
19. An investigational new drug treatment program for patients with gemcitabine: Results for over 3000 patients with pancreatic carcinoma
20. Phase II study of gemcitabine and cisplatin in advanced or metastatic pancreatic cancer
21. A phase I trial of cisplatin plus gemcitabine and radiation therapy in pancreatic cancer